Biotech News

OraSure Technologies Appoints John D. Bertrand to its Board of Directors

OraSure Technologies, Inc. (OSUR)OraSure Technologies, Inc.2026-04-17 00:10 ESTFDA / regulatory

Enters into Cooperation Agreement with Altai Capital Board to Seek Shareholder Approval for Declassification at the 2026 Annual Meeting BETHLEHEM, Pa., April 16, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure” and “OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic

Open original release

Related news

OSUROraSure Technologies, Inc.2026-01-05 13:00 EST

OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review

OSUROraSure Technologies, Inc.2026-01-15 18:00 EST

OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital

TTOOT2 Biosystems2024-10-07 13:05 EST

T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens

DGXQuest Diagnostics2026-06-24 12:52 EST

Quest Diagnostics Receives New York State Approval for Haystack MRD®, Broadening Patient Access to ctDNA Minimal Residual Disease Testing

VRAXVirax Biolabs2025-08-26 11:30 EST

Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September

AXDXAccelerate Diagnostics2025-03-21 17:52 EST

Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance

BJDXBluejay Diagnostics2025-11-10 12:30 EST

Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships

VRAXVirax Biolabs2025-11-03 13:29 EST

Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes

QGENQiagen N.V.2024-11-04 06:30 EST

QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics

QGENQiagen N.V.2024-10-29 06:30 EST

QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment

View all latest news

OraSure Technologies, Inc.

OraSure Technologies is a diagnostics company focused on sample collection, infectious-disease testing, and specimen-management products. Its business is centered on testing infrastructure rather than therapeutics.

Recent company news

OSUROraSure Technologies, Inc.2026-05-06 20:05 EST

OraSure Announces First Quarter 2026 Financial Results

OSUROraSure Technologies, Inc.2026-04-22 20:10 EST

OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th

OSUROraSure Technologies, Inc.2026-04-17 00:10 EST

OraSure Technologies Appoints John D. Bertrand to its Board of Directors

OSUROraSure Technologies, Inc.2026-03-17 20:53 EST

OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital

OSUROraSure Technologies, Inc.2026-02-25 21:05 EST

OraSure Announces Fourth Quarter 2025 Financial Results

Stock data

Close: 3.96 USD
Market cap: 275.39M USD
Exchange: NASDAQ
Sector: MedTech
Location: United States